Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Christopher Wardell

Concepts (266)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
39
2025
3082
1.890
Why?
Mutation
21
2022
1338
1.590
Why?
High-Throughput Nucleotide Sequencing
5
2021
181
0.920
Why?
Translocation, Genetic
14
2021
266
0.900
Why?
Whole Body Imaging
1
2025
25
0.870
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2025
43
0.860
Why?
Image Processing, Computer-Assisted
1
2025
235
0.790
Why?
Bone and Bones
1
2025
501
0.660
Why?
Oncogenes
2
2018
61
0.660
Why?
Tomography, X-Ray Computed
1
2025
1183
0.600
Why?
Biliary Tract Neoplasms
1
2018
5
0.540
Why?
Cholangiocarcinoma
1
2018
27
0.530
Why?
Gene Expression Profiling
14
2022
1112
0.530
Why?
Genomics
8
2022
271
0.500
Why?
Proto-Oncogene Proteins B-raf
3
2022
78
0.480
Why?
Gene Expression Regulation, Neoplastic
11
2022
868
0.470
Why?
Prognosis
15
2021
2118
0.390
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
1043
0.360
Why?
Brain Neoplasms
3
2023
319
0.360
Why?
Gene Dosage
5
2020
76
0.350
Why?
Humans
52
2025
53246
0.350
Why?
Genetic Predisposition to Disease
5
2018
533
0.350
Why?
Plasma Cells
4
2021
234
0.340
Why?
Genome, Human
4
2021
121
0.320
Why?
Evolution, Molecular
2
2021
97
0.320
Why?
Liver Neoplasms
3
2022
347
0.320
Why?
DNA Mutational Analysis
7
2020
179
0.310
Why?
Thalidomide
5
2019
378
0.300
Why?
DNA Copy Number Variations
4
2021
117
0.290
Why?
In Situ Hybridization, Fluorescence
11
2023
266
0.290
Why?
Software
2
2021
280
0.270
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
123
0.270
Why?
Neoplasm Recurrence, Local
3
2021
647
0.260
Why?
Aged
16
2025
10430
0.250
Why?
Chromosome Aberrations
6
2022
297
0.250
Why?
Carcinoma, Hepatocellular
2
2022
213
0.250
Why?
Middle Aged
18
2025
13422
0.250
Why?
Polymorphism, Single Nucleotide
3
2018
505
0.250
Why?
Male
26
2025
27444
0.240
Why?
Female
27
2025
28792
0.240
Why?
Clonal Evolution
2
2019
59
0.230
Why?
Epigenesis, Genetic
4
2018
412
0.230
Why?
Chromosomes, Human, Pair 1
2
2019
95
0.230
Why?
Immunoglobulin Heavy Chains
3
2014
46
0.220
Why?
Neoplasm Proteins
3
2017
330
0.220
Why?
Disease Progression
8
2021
880
0.210
Why?
Gene Regulatory Networks
2
2022
112
0.200
Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
24
0.190
Why?
Polycomb Repressive Complex 2
2
2021
48
0.190
Why?
Chromosomes, Human, Pair 14
5
2014
76
0.190
Why?
Central Nervous System Neoplasms
1
2023
69
0.180
Why?
Exome
4
2017
54
0.180
Why?
Hematologic Neoplasms
1
2023
101
0.180
Why?
STAT2 Transcription Factor
1
2021
6
0.180
Why?
STAT1 Transcription Factor
1
2021
28
0.180
Why?
Germ-Line Mutation
2
2021
67
0.180
Why?
Li-Fraumeni Syndrome
1
2021
11
0.180
Why?
Genome-Wide Association Study
3
2018
184
0.170
Why?
Japan
2
2018
42
0.170
Why?
Gene Frequency
2
2017
97
0.160
Why?
Aged, 80 and over
9
2021
3495
0.160
Why?
Cell Cycle
1
2021
237
0.160
Why?
Neoplasms
2
2020
1335
0.160
Why?
Glioblastoma
1
2021
101
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
DNA Methylation
3
2016
592
0.150
Why?
Leukemia, Plasma Cell
1
2020
35
0.150
Why?
Ecosystem
1
2021
99
0.150
Why?
Chromosomal Instability
1
2019
16
0.150
Why?
Genes, myc
1
2019
39
0.150
Why?
Chromosomes, Human, Pair 4
3
2014
30
0.140
Why?
Cell Survival
2
2018
600
0.140
Why?
Diploidy
2
2017
25
0.140
Why?
Chromosomes, Human, Pair 11
3
2014
56
0.140
Why?
Genes, Tumor Suppressor
2
2021
73
0.140
Why?
INDEL Mutation
1
2018
4
0.140
Why?
Mutagenesis
1
2018
59
0.140
Why?
Genes, Immunoglobulin Heavy Chain
2
2019
13
0.140
Why?
Italy
1
2018
27
0.140
Why?
Adult
13
2021
14541
0.130
Why?
Transcriptional Elongation Factors
1
2017
17
0.130
Why?
Histone-Lysine N-Methyltransferase
2
2016
56
0.130
Why?
Chromosomes, Human, Pair 5
1
2017
17
0.130
Why?
Enhancer Elements, Genetic
1
2017
60
0.130
Why?
Reproducibility of Results
1
2021
1221
0.130
Why?
Melanoma
1
2020
277
0.130
Why?
Transcriptome
4
2021
368
0.130
Why?
Chromosomes, Human
1
2017
41
0.130
Why?
Hepatocytes
1
2018
188
0.120
Why?
Immunologic Factors
1
2017
117
0.120
Why?
B-Lymphocytes
2
2016
178
0.120
Why?
Neoplasms, Multiple Primary
1
2016
44
0.120
Why?
Neoplasm Metastasis
1
2016
237
0.120
Why?
Melphalan
2
2013
180
0.110
Why?
Oligodendroglioma
1
2015
6
0.110
Why?
Skin Neoplasms
1
2020
500
0.110
Why?
Sequence Analysis, DNA
2
2016
216
0.110
Why?
ras Proteins
1
2015
64
0.110
Why?
Endoribonucleases
1
2015
17
0.110
Why?
Survival Rate
4
2020
949
0.110
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
42
0.110
Why?
Survival Analysis
5
2015
659
0.110
Why?
Endoplasmic Reticulum Stress
1
2015
51
0.110
Why?
SMN Complex Proteins
1
2014
4
0.110
Why?
RNA Processing, Post-Transcriptional
1
2014
23
0.100
Why?
Signal Transduction
5
2022
1748
0.100
Why?
Transcription Factors
2
2015
571
0.100
Why?
Chromosome Deletion
2
2011
138
0.100
Why?
Mutation Rate
3
2021
36
0.100
Why?
Cyclin D
1
2013
18
0.100
Why?
Kaplan-Meier Estimate
4
2018
487
0.100
Why?
Genes, erbB-1
1
2013
9
0.100
Why?
Nerve Tissue Proteins
1
2015
193
0.100
Why?
Cell Line, Tumor
4
2022
1470
0.100
Why?
RNA, Neoplasm
1
2013
45
0.100
Why?
Repressor Proteins
1
2014
149
0.100
Why?
Chromosome Breakage
1
2013
16
0.100
Why?
Precursor Cells, B-Lymphoid
1
2013
8
0.100
Why?
Germinal Center
1
2013
29
0.090
Why?
RNA Splicing
3
2021
43
0.090
Why?
Retrospective Studies
1
2025
6821
0.090
Why?
DNA-Binding Proteins
1
2015
423
0.090
Why?
Genetic Heterogeneity
1
2012
20
0.090
Why?
Cell Transformation, Neoplastic
1
2013
187
0.090
Why?
Acetyltransferases
1
2011
18
0.090
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
27
0.090
Why?
Antineoplastic Agents
3
2018
1232
0.090
Why?
RNA, Messenger
1
2015
1133
0.090
Why?
Chromosomes, Human, Pair 17
1
2011
35
0.090
Why?
Cell Proliferation
3
2022
1031
0.090
Why?
DNA, Neoplasm
3
2018
146
0.080
Why?
Multivariate Analysis
3
2021
598
0.080
Why?
TOR Serine-Threonine Kinases
1
2010
83
0.080
Why?
Remission Induction
2
2021
222
0.080
Why?
Phenotype
3
2022
803
0.080
Why?
Tumor Suppressor Protein p53
1
2011
228
0.080
Why?
Clone Cells
2
2021
76
0.080
Why?
MicroRNAs
1
2013
397
0.070
Why?
DNA
1
2012
535
0.070
Why?
Alleles
2
2021
277
0.070
Why?
Transcriptional Activation
2
2021
128
0.070
Why?
Spliceosomes
2
2021
10
0.070
Why?
Follow-Up Studies
3
2020
2318
0.070
Why?
Genomic Instability
2
2018
88
0.060
Why?
Epigenomics
2
2017
76
0.060
Why?
Risk Factors
3
2021
4018
0.060
Why?
Loss of Heterozygosity
2
2018
78
0.060
Why?
Disease-Free Survival
2
2019
466
0.050
Why?
Treatment Outcome
4
2019
5597
0.050
Why?
Protein Binding
2
2017
670
0.050
Why?
Chromosomes, Human, Pair 20
2
2014
11
0.050
Why?
Liver
2
2022
1150
0.050
Why?
Genotype
2
2017
563
0.050
Why?
Dexamethasone
2
2019
429
0.050
Why?
Histones
2
2016
318
0.050
Why?
Proportional Hazards Models
2
2015
445
0.050
Why?
Janus Kinase 1
1
2021
16
0.040
Why?
Janus Kinase 2
1
2021
27
0.040
Why?
Gene Rearrangement
1
2022
76
0.040
Why?
Nitriles
1
2021
55
0.040
Why?
Organoids
1
2021
41
0.040
Why?
Microarray Analysis
2
2012
69
0.040
Why?
Syndecan-1
1
2021
73
0.040
Why?
Polymerase Chain Reaction
2
2013
452
0.040
Why?
Chromosome Mapping
2
2011
145
0.040
Why?
Biomarkers, Pharmacological
2
2011
26
0.040
Why?
Cell Line
2
2015
1016
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
Cell Movement
1
2022
279
0.040
Why?
Alternative Splicing
1
2021
61
0.040
Why?
Pyrazoles
1
2021
123
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Gene Expression
2
2013
618
0.040
Why?
Pyrimidines
1
2021
206
0.040
Why?
Phosphoproteins
1
2021
117
0.040
Why?
Lymphoma, Follicular
1
2020
27
0.040
Why?
Prospective Studies
2
2016
2412
0.040
Why?
Protein Disulfide-Isomerases
1
2019
12
0.040
Why?
Recurrence
1
2021
694
0.040
Why?
Young Adult
2
2021
4514
0.040
Why?
Maintenance Chemotherapy
1
2019
52
0.040
Why?
Syndrome
1
2019
248
0.040
Why?
Transcription Elongation, Genetic
1
2017
4
0.030
Why?
Physical Chromosome Mapping
1
2017
7
0.030
Why?
Genetic Drift
1
2017
3
0.030
Why?
Gene Knockdown Techniques
1
2018
109
0.030
Why?
Caspases
1
2018
101
0.030
Why?
Genetic Loci
1
2017
48
0.030
Why?
Unfolded Protein Response
1
2017
35
0.030
Why?
Xenograft Model Antitumor Assays
1
2018
228
0.030
Why?
Mitosis
1
2017
86
0.030
Why?
Molecular Targeted Therapy
1
2018
138
0.030
Why?
Genetic Association Studies
1
2017
124
0.030
Why?
Risk
1
2017
306
0.030
Why?
Genetic Structures
1
2016
1
0.030
Why?
Algorithms
1
2020
668
0.030
Why?
Comparative Genomic Hybridization
1
2016
38
0.030
Why?
Virus Integration
1
2016
9
0.030
Why?
Computational Biology
1
2018
209
0.030
Why?
Regulatory Sequences, Nucleic Acid
1
2016
41
0.030
Why?
Nuclear Proteins
1
2017
250
0.030
Why?
Immunosuppressive Agents
1
2017
253
0.030
Why?
Flow Cytometry
1
2017
400
0.030
Why?
Antibodies, Monoclonal
1
2019
477
0.030
Why?
Minor Histocompatibility Antigens
1
2015
19
0.030
Why?
MafB Transcription Factor
1
2015
9
0.030
Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
Why?
Tumor Microenvironment
1
2017
274
0.030
Why?
Cytidine Deaminase
1
2015
13
0.030
Why?
Amino Acid Sequence
1
2016
563
0.030
Why?
RNA Stability
1
2015
29
0.030
Why?
Chromosomes, Human, Pair 16
1
2014
18
0.030
Why?
Patient Selection
1
2016
273
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2015
55
0.030
Why?
Multiplex Polymerase Chain Reaction
1
2014
12
0.030
Why?
Cytogenetic Analysis
1
2014
79
0.030
Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
Why?
Time Factors
1
2021
2992
0.030
Why?
Introns
1
2014
51
0.030
Why?
Single-Cell Analysis
1
2014
72
0.030
Why?
Methylation
1
2014
127
0.030
Why?
Base Sequence
1
2015
620
0.030
Why?
Protein Isoforms
1
2014
124
0.030
Why?
Down-Regulation
1
2015
344
0.030
Why?
High-Throughput Screening Assays
1
2013
39
0.030
Why?
Molecular Sequence Data
1
2015
759
0.030
Why?
Protein Structure, Tertiary
1
2014
252
0.030
Why?
HeLa Cells
1
2014
243
0.020
Why?
Osteonectin
1
2013
10
0.020
Why?
Chromosomes, Human, Pair 7
1
2013
29
0.020
Why?
Karyotyping
1
2013
77
0.020
Why?
Azacitidine
1
2013
39
0.020
Why?
Transforming Growth Factor beta1
1
2013
61
0.020
Why?
Mass Spectrometry
1
2014
294
0.020
Why?
Homologous Recombination
1
2013
45
0.020
Why?
Disease Models, Animal
1
2018
1517
0.020
Why?
Early Detection of Cancer
1
2014
190
0.020
Why?
Apoptosis
1
2018
1139
0.020
Why?
Tumor Suppressor Proteins
1
2013
130
0.020
Why?
Validation Studies as Topic
1
2012
10
0.020
Why?
Gene Library
1
2012
40
0.020
Why?
Laboratories
1
2012
21
0.020
Why?
Predictive Value of Tests
1
2014
933
0.020
Why?
Hemizygote
1
2011
6
0.020
Why?
Animals
2
2018
13528
0.020
Why?
Drug Resistance, Neoplasm
1
2013
350
0.020
Why?
Breast Neoplasms
1
2020
1223
0.020
Why?
Bone Marrow
1
2013
359
0.020
Why?
Vincristine
1
2010
89
0.020
Why?
Prednisolone
1
2010
56
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2011
412
0.020
Why?
Cluster Analysis
1
2010
238
0.020
Why?
Adolescent
1
2021
6912
0.020
Why?
Precancerous Conditions
1
2010
87
0.020
Why?
Cyclophosphamide
1
2010
178
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2010
136
0.020
Why?
Clinical Trials as Topic
1
2012
466
0.020
Why?
Stem Cell Transplantation
1
2010
191
0.020
Why?
Child
1
2021
7384
0.020
Why?
Models, Biological
1
2012
737
0.020
Why?
Up-Regulation
1
2010
456
0.020
Why?
Sex Factors
1
2011
747
0.020
Why?
Doxorubicin
1
2010
248
0.020
Why?
Risk Assessment
1
2013
1368
0.020
Why?
Prevalence
1
2011
1034
0.020
Why?
Mice
1
2018
5982
0.020
Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description